MiRNA-1236 inhibits HIV-1 infection of monocytes by repressing translation of cellular factor VprBP

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Li, Ma ^a,b   Shen, Chan Juan ^b   Cohen, Éric A ^c   Xiong, Si Dong ^a   Wang, Jian Hua ^b  

^a SOOCHOW UNIVERSITY   (China)

^b INSTITUTE PASTEUR OF SHANGHAI   (China)

^c CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; MESSENGER RNA; MICRORNA; MICRORNA 1236; UNCLASSIFIED DRUG; VPR PROTEIN; 3' UNTRANSLATED REGION; CARRIER PROTEIN; MIRN1236 MICRORNA, HUMAN; SMALL INTERFERING RNA; VPRBP PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DENDRITIC CELL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INHIBITION KINETICS; MONOCYTE; PROTEIN EXPRESSION; TRANSLATION REGULATION; VPRBP GENE; AGONISTS; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; GENE SILENCING; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; HEK293 CELL LINE; HOST PATHOGEN INTERACTION; HOST RANGE; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; PHYSIOLOGY; PROTEIN SYNTHESIS; REPORTER GENE; VIROLOGY;

3' UNTRANSLATED REGIONS; CARRIER PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; GENES, REPORTER; GENETIC VECTORS; HEK293 CELLS; HIV-1; HOST SPECIFICITY; HOST-PATHOGEN INTERACTIONS; HUMANS; MICRORNAS; MONOCYTES; PROTEIN BIOSYNTHESIS; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84903287333     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099535     Document Type: Article

References (54)

1. Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233.
2. Mraz M, Pospisilova S, Malinova K, Slapak I, Mayer J (2009) MicroRNAs in chronic lymphocytic leukemia pathogenesis and disease subtypes. Leuk Lymphoma 50: 506-509.
3. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, et al. (2005) A microRNA polycistron as a potential human oncogene. Nature 435: 828-833. (Pubitemid 40839734)
4. Swaminathan S, Murray D, Kelleher AD (2012) The role of miRNAs in HIV-1 pathogenesis and therapy. AIDS.
5. Duskova K, Nagilla P, Le HS, Iyer P, Thalamuthu A, et al. (2013) MicroRNA regulation and its effects on cellular transcriptome in human immunodeficiency virus-1 (HIV-1) infected individuals with distinct viral load and CD4 cell counts. BMC Infect Dis 13: 250.
6. Zhang ZN, Xu JJ, Fu YJ, Liu J, Jiang YJ, et al. (2013) Transcriptomic analysis of peripheral blood mononuclear cells in rapid progressors in early HIV infection identifies a signature closely correlated with disease progression. Clin Chem 59: 1175-1186.
7. Duan M, Yao H, Hu G, Chen X, Lund AK, et al. (2013) HIV Tat induces expression of ICAM-1 in HUVECs: implications for miR-221/-222 in HIV-associated cardiomyopathy. PLoS One 8: e60170.
8. Fowler L, Saksena NK (2013) Micro-RNA: new players in HIV-pathogenesis, diagnosis, prognosis and antiviral therapy. AIDS Rev 15: 3-14.
9. Seddiki N, Phetsouphanh C, Swaminathan S, Xu Y, Rao S, et al. (2013) The microRNA-9/B-lymphocyte-induced maturation protein-1/IL-2 axis is differentially regulated in progressive HIV infection. Eur J Immunol 43: 510-520.
10. Thapa DR, Hussain SK, Tran WC, D'Souza G, Bream JH, et al. (2014) Serum microRNAs in HIV-infected individuals as pre-diagnosis biomarkers for AIDS-related non-Hodgkin lymphomas (AIDS-NHL). J Acquir Immune Defic Syndr.
11. Gaulke CA, Porter M, Han YH, Sankaran-Walters S, Grishina I, et al. (2014) Intestinal epithelial barrier disruption through altered mucosal microRNA expression in HIV and SIV infections. J Virol.
12. Swaminathan G, Navas-Martin S, Martin-Garcia J (2014) MicroRNAs and HIV-1 Infection: Antiviral Activities and Beyond. J Mol Biol 426: 1178-1197.
13. Van Lint C, Bouchat S, Marcello A (2013) HIV-1 transcription and latency: an update. Retrovirology 10: 67.
14. Detsika MG, Psarris A, Paraskevis D (2012) MicroRNAs and HIV latency: a complex and promising relationship. AIDS Rev 14: 188-194.
15. Huang J, Wang F, Argyris E, Chen K, Liang Z, et al. (2007) Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes. Nat Med 13: 1241-1247. (Pubitemid 47530631)
16. Ahluwalia JK, Khan SZ, Soni K, Rawat P, Gupta A, et al. (2008) Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication. Retrovirology 5: 117.
17. Nathans R, Chu CY, Serquina AK, Lu CC, Cao H, et al. (2009) Cellular microRNA and P bodies modulate host-HIV-1 interactions. Mol Cell 34: 696-709.
18. Hariharan M, Scaria V, Pillai B, Brahmachari SK (2005) Targets for human encoded microRNAs in HIV genes. Biochem Biophys Res Commun 337: 1214-1218. (Pubitemid 41505253)
19. Sun G, Li H, Wu X, Covarrubias M, Scherer L, et al. (2012) Interplay between HIV-1 infection and host microRNAs. Nucleic Acids Res 40: 2181-2196.
20. Kulkarni S, Savan R, Qi Y, Gao X, Yuki Y, et al. (2011) Differential microRNA regulation of HLA-C expression and its association with HIV control. Nature 472: 495-498.
21. Kulkarni S, Qi Y, O'HUigin C, Pereyra F, Ramsuran V, et al. (2013) Genetic interplay between HLA-C and MIR148A in HIV control and Crohn disease. Proc Natl Acad Sci U S A 110: 20705-20710.
22. Chiang K, Liu H, Rice AP (2013) miR-132 enhances HIV-1 replication. Virology 438: 1-4.
23. Zhang HS, Wu TC, Sang WW, Ruan Z (2012) MiR-217 is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation by down-regulation of SIRT1. Biochim Biophys Acta 1823: 1017-1023.
24. Zhang HS, Chen XY, Wu TC, Sang WW, Ruan Z (2012) MiR-34a is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation through the SIRT1/NFkappaB pathway. FEBS Lett 586: 4203-4207.
25. Zhang Y, Fan M, Geng G, Liu B, Huang Z, et al. (2014) A novel HIV-1-encoded microRNA enhances its viral replication by targeting the TATA box region. Retrovirology 11: 23.
26. Bergamaschi A, Pancino G (2010) Host hindrance to HIV-1 replication in monocytes and macrophages. Retrovirology 7: 31.
27. Collini P, Noursadeghi M, Sabroe I, Miller RF, Dockrell DH (2010) Monocyte and macrophage dysfunction as a cause of HIV-1 induced dysfunction of innate immunity. Curr Mol Med 10: 727-740.
28. Triques K, Stevenson M (2004) Characterization of restrictions to human immunodeficiency virus type 1 infection of monocytes. J Virol 78: 5523-5527. (Pubitemid 38581504)
29. Dong C, Kwas C, Wu L (2009) Transcriptional restriction of human immunodeficiency virus type 1 gene expression in undifferentiated primary monocytes. J Virol 83: 3518-3527.
30. Arfi V, Riviere L, Jarrosson-Wuilleme L, Goujon C, Rigal D, et al. (2008) Characterization of the early steps of infection of primary blood monocytes by human immunodeficiency virus type 1. J Virol 82: 6557-6565. (Pubitemid 351875132)
31. Sonza S, Maerz A, Deacon N, Meanger J, Mills J, et al. (1996) Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes. J Virol 70: 3863-3869. (Pubitemid 26157366)
32. Neil S, Martin F, Ikeda Y, Collins M (2001) Postentry restriction to human immunodeficiency virus-based vector transduction in human monocytes. J Virol 75: 5448-5456. (Pubitemid 32488137)
33. Ellery PJ, Tippett E, Chiu YL, Paukovics G, Cameron PU, et al. (2007) The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo. J Immunol 178: 6581-6589. (Pubitemid 46717442)
34. Laguette N, Sobhian B, Casartelli N, Ringeard M, Chable-Bessia C, et al. (2011) SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 474: 654-657.
35. Hrecka K, Hao C, Gierszewska M, Swanson SK, Kesik-Brodacka M, et al. (2011) Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 474: 658-661.
36. Berger A, Sommer AF, Zwarg J, Hamdorf M, Welzel K, et al. (2011) SAMHD1-deficient CD14+ cells from individuals with Aicardi-Goutieres syndrome are highly susceptible to HIV-1 infection. PLoS Pathog 7: e1002425.
37. Lahouassa H, Daddacha W, Hofmann H, Ayinde D, Logue EC, et al. (2012) SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat Immunol 13: 223-228.
38. Sisk JM, Clements JE, Witwer KW (2012) miRNA profiles of monocyte-lineage cells are consistent with complicated roles in HIV-1 restriction. Viruses 4: 1844-1864.
39. Shen CJ, Jia YH, Tian RR, Ding M, Zhang C, et al. (2012) Translation of Puralpha is targeted by cellular miRNAs to modulate the differentiation- dependent susceptibility of monocytes to HIV-1 infection. FASEB J 26: 4755-4764.
40. Klase Z, Houzet L, Jeang KT (2012) MicroRNAs and HIV-1: complex interactions. J Biol Chem 287: 40884-40890.
41. Sung TL, Rice AP (2009) miR-198 inhibits HIV-1 gene expression and replication in monocytes and its mechanism of action appears to involve repression of cyclin T1. PLoS Pathog 5: e1000263.
42. Belzile JP, Duisit G, Rougeau N, Mercier J, Finzi A, et al. (2007) HIV-1 Vpr-mediated G2 arrest involves the DDB1-CUL4AVPRBP E3 ubiquitin ligase. PLoS Pathog 3: e85.
43. Belzile JP, Richard J, Rougeau N, Xiao Y, Cohen EA (2010) HIV-1 Vpr induces the K48-linked polyubiquitination and proteasomal degradation of target cellular proteins to activate ATR and promote G2 arrest. J Virol 84: 3320-3330.
44. Hrecka K, Gierszewska M, Srivastava S, Kozaczkiewicz L, Swanson SK, et al. (2007) Lentiviral Vpr usurps Cul4-DDB1[VprBP] E3 ubiquitin ligase to modulate cell cycle. Proc Natl Acad Sci U S A 104: 11778-11783. (Pubitemid 47175089)
45. Zhou H, Xu M, Huang Q, Gates AT, Zhang XD, et al. (2008) Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe 4: 495-504.
46. Konig R, Zhou Y, Elleder D, Diamond TL, Bonamy GM, et al. (2008) Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 135: 49-60.
47. Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, et al. (2008) Identification of host proteins required for HIV infection through a functional genomic screen. Science 319: 921-926. (Pubitemid 351263756)
48. Wang X, Singh S, Jung HY, Yang G, Jun S, et al. (2013) HIV-1 Vpr protein inhibits telomerase activity via the EDD-DDB1-VPRBP E3 ligase complex. J Biol Chem 288: 15474-15480.
49. Kogan M, Deshmane S, Sawaya BE, Gracely EJ, Khalili K, et al. (2013) Inhibition of NF-kappaB activity by HIV-1 Vpr is dependent on Vpr binding protein. J Cell Physiol 228: 781-790.
50. Gerard FC, Yang R, Romani B, Poisson A, Belzile JP, et al. (2014) Defining the Interactions and Role of DCAF1/VPRBP in the DDB1-Cullin4A E3 Ubiquitin Ligase Complex Engaged by HIV-1 Vpr to Induce a G2 Cell Cycle Arrest. PLoS One 9: e89195.
51. Laguette N, Bregnard C, Hue P, Basbous J, Yatim A, et al. (2014) Premature activation of the SLX4 complex by Vpr promotes G2/M arrest and escape from innate immune sensing. Cell 156: 134-145.
52. Ahn J, Vu T, Novince Z, Guerrero-Santoro J, Rapic-Otrin V, et al. (2010) HIV-1 Vpr loads uracil DNA glycosylase-2 onto DCAF1, a substrate recognition subunit of a cullin 4A-ring E3 ubiquitin ligase for proteasome-dependent degradation. J Biol Chem 285: 37333-37341.
53. Ahn J, Hao C, Yan J, Delucia M, Mehrens J, et al. (2012) HIV/Simian Immunodeficiency Virus (SIV) Accessory Virulence Factor Vpx Loads the Host Cell Restriction Factor SAMHD1 onto the E3 Ubiquitin Ligase Complex CRL4DCAF1. J Biol Chem 287: 12550-12558.
54. Qin Y, Li Y, Liu W, Tian R, Guo Q, et al. (2011) Penicillium marneffei-stimulated dendritic cells enhance HIV-1 trans-infection and promote viral infection by activating primary CD4+ T cells. PLoS ONE 6: e27609.